Proceedings of the VIIth International Pneumoconioses Conference, August 23-26, 1988, Pittsburgh, Pennsylvania, USA. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 90-108, 1990 Sep; (Part I):443-451
An investigation was conducted to evaluate the effectiveness of the inhaled corticosteroids in the treatment of occupational respiratory diseases. The investigation involved 15 patients aged 28 to 66 years. Nine had a consistent occupational history of exposition to mineral dusts (five to silica (14808607), three to iron (7439896), and one to asbestos (1332214)), and six to organic dust (three to cork dust and three to pigeon droppings). Prior to treatment all patients had complaints of exertion dyspnea, 93% experienced cough, 53% expectoration, and 46% wheezing. All patients were treated with Budesonide 4x200 micrograms twice a day, via a 750 milliliter spacer. After 3 months of treatment the clinical evaluation stated an improvement in 80% of the patients. The only side effects were two cases of mild sore throats and one of hoarseness. The results provided some evidence of the effectiveness of the proposed treatment, mainly in the interstitial occupational respiratory diseases.
Epidemiology; Silica dusts; Dust inhalation; Dust exposure; Respiratory system disorders; Pulmonary function tests; Medical treatment; Asbestos workers; Pigeon breeders disease; Plant dusts
14808-60-7; 7439-89-6; 1332-21-4
DHHS (NIOSH) Publication No. 90-108
Proceedings of the VIIth International Pneumoconioses Conference, August 23-26, 1988, Pittsburgh, Pennsylvania, USA
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.